Sgs Pharmaceutical Pvt Ltd, a active private limited company, was established on 08 May 2001 in New Elhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239DL2001PTC110738. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹1.30 Cr.
It upholds a compliant status. Employing 62 professional, Its leadership includes Nimish Gupta (Director), Manvendra Singh (Director). Past directors included Anita Gupta, Vipin Gupta, Pramod Kumar. It holds ₹15.22 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1608 Dewan Hall Building6/2 Ist Floor Bhagirathi Place, New Elhi, Delhi, 110006.
U24239DL2001PTC110738
110738
08 May 2001
₹1.75 Cr
₹1.30 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Sgs Pharmaceutical Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nimish Gupta | Director | 20 Feb 2007 | Current |
| Manvendra Singh | Director | 30 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2014 | Past |
| Pramod Abcsdd | Director | 21 Feb 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sgs Pharmaceutical Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.66% decrease. The company also saw a substantial improvement in profitability, with a 14.48% increase in profit. The company's net worth Soared by an impressive increase of 14.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Sgs Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹152,157,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2020 | Hdfc Bank Limited | ₹3.50 M | Open |
| 04 Jan 2006 | State Bank Of India | ₹10.51 Cr | Open |
| 04 Jan 2006 | State Bank Of India | ₹3.36 Cr | Open |
| 04 Jan 2006 | State Bank Of India | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Sgs Pharmaceutical has a workforce of 62 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sgs Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sgs Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sgs Pharmaceutical Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Sgs Pharmaceutical Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with State Bank Of India of Rs. 10.51 Cr registered on 04 Jan 2006 with Charge ID 80061610 was modified on 10 Jul 2023. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.35 Cr with Charge ID 100418251 was registered on 29 Oct 2020. was recorded as a recent event.
The activity Manvendra Singh was appointed as a Director was appointed as a Director on 30 Jan 2019 & has been associated with this company since 6 years 10 months . was completed.
The activity A charge with State Bank Of India of Rs. 3.36 Cr registered on 04 Jan 2006 with Charge ID 90331256 was modified on 29 Nov 2010. was completed.
SGS now has better techniques for collecting and using PBMCs in early clinical trials, making them a top choice for infectious disease and vaccine research. These cells are important for studying diseases and biological effects, but can be tricky to handle. SGS has developed new processes, like all-in-one tubes, to make it easier and more efficient..
The CIN of Sgs Pharmaceutical Pvt Ltd is U24239DL2001PTC110738.
Sgs Pharmaceutical Pvt Ltd is headquartered at 1608 Dewan Hall Building6/2 Ist Floor Bhagirathi Place, New Elhi, Delhi, 110006.
Sgs Pharmaceutical Pvt Ltd was incorporated on 08 May 2001.
The current directors of Sgs Pharmaceutical Pvt Ltd are
The primary industry of Sgs Pharmaceutical Pvt Ltd is Manufacturing.
Sgs Pharmaceutical Pvt Ltd is unlisted.
The authorized capital of Sgs Pharmaceutical Pvt Ltd is ₹1.75 Cr, and the paid-up capital is ₹1.30 Cr.
The compliance status of Sgs Pharmaceutical Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX